Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma.

[1]  K. Ang,et al.  Toward improving the therapeutic ratio in stereotactic radiosurgery: selective modulation of the radiation responses of both normal tissues and tumor. , 2007, Journal of neurosurgery.

[2]  Jin-Ching Lin,et al.  Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma. , 2006, International journal of radiation oncology, biology, physics.

[3]  J. Sham,et al.  Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. , 2006, International journal of radiation oncology, biology, physics.

[4]  B. O'Sullivan,et al.  Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma. , 2006, International journal of radiation oncology, biology, physics.

[5]  N. Mayr,et al.  Dose escalation of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma: a prospective randomised study. , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

[6]  Sang‐wook Lee,et al.  Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma. , 2006, International journal of radiation oncology, biology, physics.

[7]  S. Leung,et al.  Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG). , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  J. Sham,et al.  Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. , 2006, International journal of radiation oncology, biology, physics.

[9]  F. Wong,et al.  Nasopharyngeal intracavitary brachytherapy , 2005, Cancer.

[10]  B. O'Sullivan,et al.  Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  D. Machin,et al.  Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  S. Leung,et al.  Survival outcome of patients with nasopharyngeal carcinoma with first local failure: A study by the Hong Kong Nasopharyngeal Carcinoma Study Group , 2005, Head & neck.

[13]  S. Leung,et al.  Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. , 2004, International journal of radiation oncology, biology, physics.

[14]  Z. Chong.  Improved local control with intensity modulated radiation therapy in patients with nasopharyngeal carcinoma , 2004 .

[15]  P. Xia,et al.  Intensity modulated radiation therapy for carcinoma of the nasopharynx: An update of the UCSF experience , 2004 .

[16]  Chen-Yi Hsu,et al.  Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Steven D Chang,et al.  Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. , 2002, International journal of radiation oncology, biology, physics.

[18]  J. Fowler,et al.  Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time. , 2002, International journal of radiation oncology, biology, physics.

[19]  P. Levendag,et al.  Role of endocavitary brachytherapy with or without chemotherapy in cancer of the nasopharynx. , 2002, International journal of radiation oncology, biology, physics.

[20]  P. Xia,et al.  Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. , 2001, International journal of radiation oncology, biology, physics.

[21]  K. Rosenzweig,et al.  Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma. , 2001, International journal of radiation oncology, biology, physics.

[22]  S. Leung,et al.  Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. , 2000, International journal of radiation oncology, biology, physics.

[23]  Y. F. Poon,et al.  Recurrent nasopharyngeal carcinoma: the puzzles of long latency. , 1999, International journal of radiation oncology, biology, physics.

[24]  J. Cooper,et al.  Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  J. Adler,et al.  Radiosurgery for skull base malignancies and nasopharyngeal carcinoma. , 1997, International journal of radiation oncology, biology, physics.

[26]  A. Garden,et al.  Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. , 1997, International journal of radiation oncology, biology, physics.

[27]  L. See,et al.  The role of brachytherapy in early-stage nasopharyngeal carcinoma. , 1996, International journal of radiation oncology, biology, physics.

[28]  Y. F. Poon,et al.  Nasopharyngeal carcinoma: local control by megavoltage irradiation. , 1993, The British journal of radiology.

[29]  C. C. Wang.  Improved Local Control of Nasopharyngeal Carcinoma After Intracavitary Brachytherapy Boost , 1991, American journal of clinical oncology.

[30]  W. Cai,et al.  Management of local residual primary lesion of nasopharyngeal carcinoma (NPC): are higher doses beneficial? , 1989, International journal of radiation oncology, biology, physics.

[31]  K. Riding,et al.  Cancer of the Nasopharynx in British Columbia , 1986, American journal of clinical oncology.

[32]  E. Strong,et al.  Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site. , 1985, International journal of radiation oncology, biology, physics.

[33]  R. Hoppe,et al.  Carcinoma of the nasopharynx. Eighteen years' experience with megavoltage radiation therapy , 1976, Cancer.

[34]  M. Zelefsky,et al.  Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. , 2006, International journal of radiation oncology, biology, physics.

[35]  J. Adler,et al.  Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control. , 1999, International journal of radiation oncology, biology, physics.

[36]  C. Perez,et al.  Carcinoma of the nasopharynx: factors affecting prognosis. , 1992, International journal of radiation oncology, biology, physics.